Increased risk organ transplantation in the pediatric population

Sean M Wrenn1,2, Peter W Callas1,2, Trishul Kapoor1,3

  • 1Department of Surgery, Larner College of Medicine at The University of Vermont, Burlington, VT, USA.

Pediatric Transplantation
|September 19, 2017
PubMed

Insights

Organs from deceased donors with infectious disease risk (IRD) show similar patient and graft survival rates in pediatric kidney and liver transplants. Increased utilization of IRD organs could improve transplant access and reduce wait times.

Area of Science:

  • Transplantation immunology
  • Infectious disease in transplantation
  • Pediatric surgery

Background:

  • Organs from donors with infectious disease risk (IRD) are underutilized, especially in pediatric transplant recipients, due to perceived risks of viral transmission (HIV, Hepatitis B/C).
  • This underutilization contributes to longer wait times and associated morbidity/mortality for pediatric patients awaiting organ transplantation.

Purpose of the Study:

  • To evaluate the outcomes of pediatric kidney and liver transplants utilizing organs from donors with infectious disease risk (IRD) compared to standard risk (SRD) donors.
  • To analyze organ acceptance rates, waitlist times, and infectious transmissions associated with IRD organ utilization in pediatric recipients.

Main Methods:

  • Retrospective analysis of the United Network for Organ Sharing (UNOS) database for pediatric renal and hepatic transplants (2004-2008).
  • Comparison of patient and graft survival between IRD and SRD organs using proportional hazards regression.
  • Analysis of organ acceptance rates, waitlist duration, and reported infectious transmissions.

Main Results:

  • No statistically significant differences in patient or graft survival were observed between IRD and SRD kidney or liver transplants.
  • Organ acceptance rates for IRD kidneys (1.5%) and livers (1.99%) were lower than for SRD organs (4.82% and 4.51%, respectively).
  • A single bloodborne pathogen transmission was reported across 7797 unique transplants from 2008-2015, indicating a low transmission risk.

Conclusions:

  • Pediatric kidney and liver transplants using IRD organs demonstrate comparable survival outcomes to those using SRD organs.
  • Increasing the utilization of IRD organs could significantly improve access to transplantation for pediatric patients.
  • Wider acceptance of IRD organs may reduce transplant wait times and mitigate risks associated with prolonged waitlist periods.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
552
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
512
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.7K
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
433
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
302